QBI Seminar: 'Amyloid-beta impairs interleukin-1β signaling: impact on Alzheimer’s Disease'
Event Details
Event Contact
Event Description
- Full Description:
- Dr Alessandra C. Martini, Institute for Memory Impairments and Neurological Disorders, University of California - Irvine (UCI)
Title: 'Amyloid-beta impairs interleukin-1β signaling: impact on Alzheimer’s Disease'
Abstract: Inflammation is a fundamental protective response, but if it becomes dysregulated it can be a major cofactor in the pathogenesis of many chronic human diseases, including Alzheimer disease (AD). Interleukin-1β (IL-1β)-mediated chronic inflammation represents a key mechanism by which Aβ drives the development of synaptic impairment and cognitive decline in AD. The pro-inflammatory activities of IL-1β are regulated at three levels: synthesis and release; activation/degradation of the membrane receptor; and intracellular signal transduction, all of which are tightly controlled to ensure proper activation and resolution of immune responses. The disruption of these processes may cause excessive inflammatory responses, however, the underlying mechanisms by which Aβ modulates IL-1β signaling remain unknown. We aim to evaluate if changes in intracellular protein clearance and trafficking are early Aβ-triggered events leading to exacerbated IL-1β-mediated inflammation, which in turn elicits tau pathology, synaptic dysfunction and cognitive decline.
Directions to UQ
Event Tools
Share This Event
Print
Email
Share
Rate This Event
Tweet This Event
Calendar Tools
Featured Calendars
Subscribe via RSS